By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Private equity firm Linden LLC has paid an undisclosed sum to purchase the Hycor Biomedical business of Agilent Technologies.

Hycor, which specializes in allergy, autoimmune, and urinalysis diagnostics, became part of Agilent through that firm's 2007 acquisition of Stratagene. Hycor had only been part of Stratagene for a few years before the deal with Agilent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genomic analysis of high-grade serous ovarian cancer, and more.

The new Riken president outlines some of his plans for the institute.

The Guardian discusses whether big science projects are worth the loss of resources available for other scientific pursuits.

An NEJM update from the ClinVar team highlights the difficulties of interpreting genetic variants.